本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Jaguar Animal Health, Inc.

8.06
+1.3920.84%
盘后8.01-0.0500-0.62%17:35 EDT
成交量:5.92万
成交额:46.55万
市值:543.28万
市盈率:-0.06
高:8.61
开:6.78
低:6.78
收:6.67
数据加载中...

公司资料

公司名字:
Jaguar Animal Health, Inc.
交易所:
NASDAQ
成立时间:
- -
员工人数:
49
公司地址:
200 Pine Street,Suite 400,San Francisco,California,United States
邮编:
94104
电话:
传真:
- -
简介:
Jaguar Health, Inc.于2013年6月6日在特拉华州成立。该公司是一家商业阶段的制药公司,专注于为患有胃肠道(“GI”)疾病的人和动物开发可持续地从雨林地区的植物中提取的新型专利处方药。

董事

名称
职位
James J. Bochnowski
Chairman of the Board
Lisa A. Conte
Chief Executive Officer, President and Director
Anula Jayasuriya
Director
John Micek III
Director
Jonathan B. Siegel
Director

股东

名称
职位
Lisa A. Conte
Chief Executive Officer, President and Director
Carol R. Lizak
Chief Financial Officer
Ian Wendt
Chief Commercial Officer
Jonathan S. Wolin
Chief of Staff, General Counsel and Chief Compliance Officer
Pravin Chaturvedi
Chief Scientific Officer
Steven R. King
Chief of Sustainable Supply, Ethnobotanical Research and Intellectual Property and Secretary